Glaxo open to spinning off consumer healthcare business

GlaxoSmithKline’s (NYSE:GSK) chief exec has announced the possibility of spinning off the group's consumer healthcare business in the future, should it offer more value as a standalone company.

Sir Andrew Witty outlined that there were no such plans in the near term but is open to the idea of further restructuring.

Glaxo has faced many challenges this year, including global bribery scandals and last week's guidance cut due to slipping sales and profit.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs